Eva Vlčková
Masaryk University
Network
Latest external collaboration on country level. Dive into details by clicking on the dots.
Publication
Featured researches published by Eva Vlčková.
Brain and behavior | 2017
Iva Šrotová; Eva Vlčková; Ladislav Dušek; Josef Bednarik
A‐waves, which are observed following the M‐wave during motor nerve conduction studies (NCS), are late responses that are frequently found in many types of neurogenic disorders. However, A‐waves are also common in healthy individuals, where their significance remains unclear. The aim of this study was to examine whether the occurrence of A‐waves does in fact represent an increased risk for the future development of changes upon NCS or needle electromyography (EMG) in the corresponding nerve.
Clinical Neurophysiology | 2016
Josef Bednarik; S. Divisova; Eva Vlčková; Iva Šrotová; S. Kincova; M. Skorna; Ladislav Dušek; P. Dubovy
We aimed to confirm usefulness of intraepidermal nerve fiber density (IENFD) as a marker of progression of diabetic polyneuropathy (DPN) in patients with early type 2 diabetes mellitus (DM2). In a group of 23 healthy subjects (median age 57xa0years, 14xa0men) and 30 DM2 patients (median age 60xa0years, 17xa0men) we serially evaluated skin biopsies from distal leg. Eighteen DM2 patients complied with the criteria of symptomatic diabetic polyneuropathy (DPN) and 12 had no neuropathy (nDPN). Time interval between biopsies were >2xa0years (median, range: 29.6, 24.7–58.4, and 33.8, 25.5–54.1xa0months in controls and DM2 patients, respectively). At first skin biopsy, the IENFD was normal in all controls and nDPN patients compared to abnormal IENFD in 77.8% of DPN patients. Drop in IENFD expressed as a proportion of the 1st IENFD value in % per year in both painful and painless DPN patients was significantly higher (11.95[3.82]%/year, p In conclusion, decrease in IENFD values in early DM2 patients is about 12% of the initial IENFD value irrespective of symptoms and/or signs of DPN at initial evaluation and several times quicker compared to healthy subjects.
Scripta medica | 2005
Eva Vlčková; Josef Bednařík; Adam Svobodník; Ladislav Dušek
Archive | 2017
Jana Raputová; Eva Vlčková; Jan Kočica; Tomáš Skutil; Aneta Rajdová; David Kec; Josef Bednařík
Archive | 2017
Aneta Rajdová; Eva Vlčková; Ivana Kovaľová; Magda Horáková; Jana Raputová; Monika Tvrdá; David Kec; Josef Bednařík
Archive | 2016
Jana Raputová; Eva Vlčková; Josef Bednařík; Jan Kočica; Tomáš Skutil
Archive | 2015
Iva Šrotová; Eva Vlčková; Jana Straková; Soňa Kincová; Luděk Ryba; Ladislav Dušek; Blanka Adamová; Josef Bednařík
Journal of the Neurological Sciences | 2013
Eva Vlčková; Iva Okáčová; Roman Kopáčik; M. Hnojcikova; Petra Praksová; B. Micankova-Adamova; Josef Bednarik
Archive | 2012
Eva Vlčková; Šárka Divišová; Mária Hnojčíková; Martin Němec; Josef Bednařík
Archive | 2012
Mária Hnojčíková; Eva Vlčková; Iva Okáčová; Petra Praksová; Šárka Divišová; Josef Bednařík